The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(5-chloro-2-hydroxy-3-methoxybenzylidene)-1-(3-chloro-4-fluorophenyl)pyrazolidine-3,5-dione ID: ALA1668290
PubChem CID: 1220388
Max Phase: Preclinical
Molecular Formula: C17H11Cl2FN2O4
Molecular Weight: 397.19
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(Cl)cc(/C=C2\C(=O)NN(c3ccc(F)c(Cl)c3)C2=O)c1O
Standard InChI: InChI=1S/C17H11Cl2FN2O4/c1-26-14-6-9(18)4-8(15(14)23)5-11-16(24)21-22(17(11)25)10-2-3-13(20)12(19)7-10/h2-7,23H,1H3,(H,21,24)/b11-5+
Standard InChI Key: GWJIIYQQCOQSJU-VZUCSPMQSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
9.2146 1.5124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2135 0.6852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9283 0.2723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6446 0.6856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6419 1.5161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9265 1.9252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3598 0.2743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0311 0.7541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9240 2.7501 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
12.8141 0.4922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3044 1.1557 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.8248 1.8270 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.0383 1.5782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3749 2.0686 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.0626 -0.2945 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.1292 1.1491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5329 0.4294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3571 0.4224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7760 1.1340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3649 1.8542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5420 1.8576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9281 -0.5527 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.4988 0.2732 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.7846 0.6863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7805 2.5667 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
16.6010 1.1285 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12 13 1 0
13 8 1 0
1 2 2 0
13 14 2 0
4 7 1 0
10 15 2 0
3 4 2 0
11 16 1 0
7 8 2 0
16 17 2 0
17 18 1 0
6 9 1 0
18 19 2 0
8 10 1 0
19 20 1 0
4 5 1 0
20 21 2 0
21 16 1 0
2 3 1 0
3 22 1 0
5 6 2 0
2 23 1 0
6 1 1 0
23 24 1 0
10 11 1 0
20 25 1 0
11 12 1 0
19 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 397.19Molecular Weight (Monoisotopic): 396.0080AlogP: 3.31#Rotatable Bonds: 3Polar Surface Area: 78.87Molecular Species: ACIDHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 6.17CX Basic pKa: ┄CX LogP: 3.32CX LogD: 2.53Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.62Np Likeness Score: -1.62
References 1. Chu Y, Chen X, Yang Y, Tang Y.. (2011) Identification of small molecular inhibitors for Ero1p by structure-based virtual screening., 21 (4): [PMID:21269829 ] [10.1016/j.bmcl.2010.12.129 ]